Over the Counter

Mitch Lamb, PharmD, joins Over the Counter to discuss pharmacy accreditation hurdles and why staying consistently proactive can mean the world for a pharmacy's bottom line.

Cencora representatives Matt Sample and Neal Cooper join Over the Counter to discuss the FDA's 7-year push to move national drug codes from 10 to 12 universal digits.

Walgreens Chief Pharmacy Officer Rick Gates joins Over the Counter to discuss his organization's newly introduced hybrid pharmacist role and how it is creating innovation across the greater pharmacy industry.

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, joins Over the Counter to discuss recent comments from FDA Commissioner Marty Makary, MD, MPH, and what they could mean for the pharmacy profession going forward.

William A. Bryson, PharmD, joins Over the Counter for a bonus rendition celebrating Diabetes Alert Day on March 24.

Annie Lambert, PharmD, BCSCP, joins Over the Counter to discuss the safety and scrutiny of compounded GLP-1s and the pharmacist's role in helping patients understand their clinical impact.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, joins Over the Counter to discuss the constant challenges pharmacies are faced with regarding drug shortages as well as the tools and approaches to overcome them.

Matt Sample, senior vice president of manufacturer, quality, and replenishment operations at Cencora, joins Over the Counter to discuss key updates under the DSCSA that independent pharmacies need to look out for in 2026.

Tim Drapeau, CEO of CLIAwaived Inc, joined Over the Counter to discuss the Test Yourself @ Home tool and how it is bridging care gaps between patients, pharmacists, and other providers.

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

Jesse Dresser, Esq, joined Over the Counter to provide necessary insights into recently signed PBM reform set to revolutionize the distribution of pharmacy benefits.

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

Chad Worz, PharmD, BCGP, FASCP, and James Lewis, from the American Society of Consultant Pharmacists (ASCP), joined Over the Counter to discuss the Inflation Reduction Act's industry-wide changes kicking off in 2026.

Meagan Brown, PharmD, BCACP, joined Over the Counter to celebrate National Pharmacist Day and discuss the various avenues for expanding pharmacists' scope.

Susan Thomas, RN, joined Over the Counter to discuss women's health, the pharmacist's role, and her organization's newly launched program designed to benefit both patients and providers.

Jennifer Flynn, CPHRM, joined Over the Counter to discuss pharmacists' potential risks and benefits when using social media for professional or personal purposes.

Kenric B. Ware, PharmD, MBA, AAHIVP, joined Over the Counter to discuss stigmas surrounding HIV care and prevention as well as the pharmacist's role in advancing management of the condition.

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.

Megan Smith, PharmD, joined Over the Counter to discuss continuously updated pneumococcal vaccines and the pharmacist's role among the greater health care community in managing pneumococcal diseases.

John C. Goodman, PhD, joined Over the Counter to discuss TrumpRx and this presidential administration's plans for lowering drug prices in the years to come.

Catie Stimmel, PharmD, joined Over the Counter to discuss the importance of patient safety organizations for the greater health care continuum.

Rick Sage, executive vice president of innovation and standards at NCPDP, joined Over the Counter to discuss the lasting impacts of the government shutdown on pharmacy and how it affected industry processes heading into 2026.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, joined Over the Counter to discuss both state and federal PBM reform heading into the new year.